MicroRNAs in cancer: Personalizing diagnosis and therapy

  • Nana-Sinkam S
  • Fabbri M
  • Croce C
  • 38

    Readers

    Mendeley users who have this article in their library.
  • 23

    Citations

    Citations of this article.

Abstract

MicroRNAs (miRNAs) are 19-24nt noncoding RNAs that have been implicated in the pathogenesis of both solid and hematological malignancies. Frequently located in fragile chromosomal regions, miRNAs are essential to key biological functions, such as cellular differentiation, apoptosis, and growth. miRNAs may serve as either tumor suppressors or oncogenes. As a result, they have the potential to serve as both biomarkers and therapeutic agents in cancer. Based on our presentation at the recent Towards Personalized Cancer Medicine conference held in Barcelona, Spain, May 19-21, 2010, we provide an overview of the current knowledge of miRNA deregulation in solid and hematological malignancies and their application as biomarkers of disease.

Author-supplied keywords

  • Biomarkers
  • Cancer
  • Genome
  • MicroRNA

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • S. Patrick Nana-Sinkam

  • Muller Fabbri

  • Carlo M. Croce

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free